A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of People With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab

Mise à jour : Il y a 4 ans
Référence : NCT00845039

Femme et Homme

Extrait

The purpose of this study is to determine the value of adding IMC-A12 to irinotecan and cetuximab in patients with metastatic colorectal cancer.


Critère d'inclusion

  • colon cancer ,Rectal cancer

Liens